Neogen (NEOG) Received An FDA Warning Over Contaminated Veterinary Product

Neogen (NasdaqGS:NEOG) received a formal FDA warning letter tied to contamination issues in its HYCOAT(R) veterinary product. Regulators cited significant manufacturing violations at HYCOAT(R) production facilities that they linked to serious adverse events in horses. The FDA findings referenced multiple horse deaths following HYCOAT(R) use and triggered a recall of affected product lots. The HYCOAT(R) contamination and FDA warning letter give important context, but investors need a wider...